One Health Antimicrobial Resistance (OHAR)
The OHAR group conducts research on discovery and development of solutions for improving diagnosis and antimicrobial therapy of bacterial infections in veterinary medicine using a One Health approach based on the recognition that the health of people is connected to the health of animals. The group has two strategic focus areas:
- to improve animal health and herd management by optimizing use, performance and impact of diagnostic tests, methods and procedures (see research projects on diagnostics here)
- to minimize development of antimicrobial resistance by optimizing use, choice, dosage and duration of antimicrobial therapy (see research and projects on therapy here)
The group participates in the Marie Curie Combatting Antimicrobial Resistance Network (CARTNET, 2018-2022) and the JPIAMR Global Antimicrobial Resistance Platform for ONE Burden Estimates (GAP-ONE, 2019-2020). In the recent past, we established the University of Copenhagen Research Centre for Control of Antibiotic Resistance (UC-Care, 2012-2016) and coordinated or participated in numerous EU projects such as PILGRIM (2009-2011), EvoTAR (2011-2015), CALLISTO (2012-2015) and TRAIN-ASAP (2012-2016).
We are responsible for one of the largest diagnostic laboratories that offers microbiology services to companion animal clinics in Denmark (SUND VET DIAGNOSTIK) and are actively involved in several international veterinary committees. The group leader, Prof. Luca Guardabassi, chairs the ESCMID Study Group for Veterinary Microbiology (ESGVM) and the WSAVA Therapeutic Guidelines Group, and is a member of the WSAVA One Health Committee and the ISCAID Antimicrobial Guidelines Working Group. The deputy leader, Associate Prof. Peter Damborg, is the chair of the European Veterinary Subcommittee on Antimicrobial Susceptibility Testing (VetCAST).